David Brenner named Sanford Burnham Prebys president and CEO

The Board of Directors of Sanford Burnham Prebys is pleased to announce the appointment of David Brenner, M.D., as the Institute’s next president and chief executive officer.

How a single protein could unlock age-related vision loss

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss.

Inhibiting key metabolic enzyme shows promise against melanoma

Institute researchers have shown for the first time that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth.